International market boosts Dr Reddy's revenue
India-based Dr Reddy's Laboratories has boosted its revenue by 168 per cent for the 2006 year, fuelled by a strengthening position in the international market.
India-based Dr Reddy's Laboratories has boosted its revenue by 168 per cent for the 2006 year, fuelled by a strengthening position in the international market.
A young start-up company is gearing up to challenge the likes of Pfizer by developing a new insulin product, based on its novel nano-based intranasal delivery technology.
Thailand is the first recipient of six major grants the World Health Organization (WHO) is distributing to developing countries to establish in-country manufacturing capacity for influenza vaccine.
Novel tabletting technology developed by US company ACCU-BREAK Pharmaceuticals promises to solve the problem of uneven doses when pills are split by hand.
The first contract research service alliance (CROSA) in China has been formed between three leading local firms to provide a more exhaustive range of drug development services to pharma companies.
Canada-based Draxis Health has passed a US Food and Drug Administration (FDA) inspection with flying colours after contracting out its manufacturing services to two new clients.
US firms Quintiles and Thermo Fisher have formed a joint venture to provide eClinical solutions to pharma and biotech companies.
A non-invasive technique that uses hair plucked from cancer patients to guide the development of new chemotherapy drugs has attracted the attention of UK pharma giant AstraZeneca.